Inactive Instrument

Acacia Diversified Holdings, Inc.

ACCA

US00389L1044

Acacia Diversified Holdings, Inc. Announces Changes to Its Board

June 04, 2020 at 02:39 pm

Acacia Diversified Holdings, Inc. announced that On May 20, 2020, directors Danny Gibbs, Neil B. Gholson and Richard Paula each resigned their respective positions as a director.

Latest news about Acacia Diversified Holdings, Inc.

Acacia Diversified Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	07/08/20	CI
Acacia Diversified Holdings, Inc. Announces Appointment of Timothy L Matthews, Jr to the Board of Directors and as President	06/08/20	CI
Acacia Diversified Holdings, Inc. cancelled the transaction announced on July 29, 2019	28/07/20	CI
Acacia Diversified Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	26/06/20	CI
Acacia Diversified Holdings, Inc. Auditor Raises 'Going Concern' Doubt	25/06/20	CI
Acacia Diversified Holdings, Inc. Announces Changes to Its Board	04/06/20	CI
Acacia Diversified Holdings, Inc. Announces the Appointment of Larnell C. Simpson, Jr as a Director of the Company	13/05/20	CI
Acacia Diversified Holdings, Inc. Announces the Resignation of Richard K. Pertile as Chairman of the Board of Directors, Chief Executive Officer and Chief Financial Officer	31/03/20	CI
Acacia Diversified Holdings, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	12/11/19	CI
Acacia Diversified Holdings, Inc. is Announcing Its Receipt of Its Second Food Grade Manufactures Permit in the Company's Mobile Fleet	27/09/19	CI
Acacia Diversified Holdings, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	09/08/19	CI
Acacia Diversified Holdings, Inc. announced a financing transaction	28/07/19	CI
ACCA and Atlas Copco Pakistan Collaborates to Develop Future-Ready Talent to Meet the Requirements of a Digital Age	16/05/19	CI
Acacia Diversified Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	15/05/19	CI
Acacia Diversified Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2018	01/04/19	CI
Acacia Diversified Holdings, Inc. Auditor Raises 'Going Concern' Doubt	31/03/19	CI
Acacia Diversified Holdings, Inc. Announces Hemp Research Partnership with Tennessee State University	14/02/19	CI
Acacia Diversified Holdings, Inc. Appoints Richard Paula as New Board Member	19/09/18	CI
Acacia Diversified Holdings, Inc. acquired MEDAHUB Operations Group, Inc. and MEDAHUB, Inc.	29/07/18	CI
Acacia Diversified Holdings, Inc. Auditor Raises 'Going Concern' Doubt	01/04/18	CI
Acacia Diversified Holdings, Inc. Appoints Lisa Smith as Secretary	27/04/17	CI
Acacia Diversified Holdings, Inc. announced that it expects to receive $5 million in funding from Peak One Investments, LLC	20/04/17	CI
Acacia Diversified Holdings, Inc. Auditor Raises 'Going Concern' Doubt	27/03/17	CI
Acacia Diversified Holdings, Inc. announced that it expects to receive $0.36 million in funding from Peak One Investments, LLC	24/03/17	CI
Steven L. Sample to Resign from Acacia Diversified Holdings, Inc. as Director	24/01/17	CI

Chart Acacia Diversified Holdings, Inc.

Duration

Period

More charts

Acacia Diversified Holdings, Inc. is a diversified holding company. The Company focuses on conducting its business operations through its subsidiaries, such as MariJ Pharmaceuticals, Inc. (MariJ), and Canna-Cures Research & Development Center, Inc., in which it focuses on including the operations of the MariJ Agricultural and Canna-Cures entities. MariJ focuses on the extraction and processing of high-cannabidiol (CBD)/low-tetrahydrocannabinol (THC) content medical grade cannabis oils from medical cannabis plants. MariJ has a mobile cannabis oil processing and extraction unit designed into a heavy-duty vehicle. The unit is engaged in the extractions and processing of medical organic hemp into oils at various sites, and is developing additional contracts for services. The Company, through Canna-Cures Research & Development Center, Inc., focuses on research and development activities, as well as retail and wholesale distribution of medical cannabis products and dietary supplements.

Sector

Pharmaceuticals

More about the company

Sector Alternative Medicine

	1st Jan change	Capi.
DONG-E-E-JIAO CO.,LTD.	+41.50%	6.2B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-22.89%	4.09B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+9.36%	3.48B
TASLY PHARMACEUTICAL GROUP CO., LTD	-19.39%	2.82B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-11.05%	2.28B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+45.24%	1.94B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+46.81%	1.53B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-7.51%	1.51B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-18.04%	1.47B

Alternative Medicine